Takada Kenzo

USPTO Trademark & Patent Filings

Takada Kenzo

Trademark applications and grants for Takada Kenzo. Takada Kenzo has 10 trademark applications. The latest application filed is for "TAKADA"

Company Profile
    Company Aliases
  • Kenzo Takada
  • TAKADA KENZO
  • Takada, Kenzo
  • kenzo takada
  • TAKADA; Kenzo - Hokkaido JP
  • Takada; Kenzo - Hokkaido JP
  • Takada; Kenzo - Sapporo JP

Trademarks Patents
Patent Applications
Patent ApplicationDate
HUMANIZED ANTl-HMGB1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF
20150361164 - 14/761152 TAKADA; Kenzo ;   et al.
2015-12-17
HUMAN ANTIBODY SPECIFIC TO HUMAN METAPNEUMOVIRUS, OR ANTIGEN-BINDING FRAGMENT THEREOF
20150322137 - 14/761879 TAKADA; Kenzo ;   et al.
2015-11-12
HUMAN ANTIBODY SPECIFIC TO TOXIN PRODUCED FROM CLOSTRIDIUM DIFFICILE, OR ANTIGEN-BINDING FRAGMENT THEREOF
20150259402 - 14/436057 Takada; Kenzo ;   et al.
2015-09-17
MONOCLONAL ANTIBODIES THAT BIND TO HGM-CSF AND MEDICAL COMPOSITIONS COMPRISING SAME
20140205611 - 14/166803 Takada; Kenzo ;   et al.
2014-07-24
MONOCLONAL ANTIBODY CAPABLE OF BINDING TO SPECIFIC DISCONTINUOUS EPITOPE OCCURRING IN AD1 REGION OF HUMAN CYTOMEGALOVIRUS GB GLYCOPROTEIN, AND ANTIGEN-BINDING FRAGMENT THEREOF
20120093810 - 13/262061 Takada; Kenzo ;   et al.
2012-04-19
Humanized anti-HMGB1 antibody or antigen-binding fragment thereof
9,550,825 - 14/761,152 Takada , et al. January 24, 2
2017-01-24
Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same
8,679,502 - 12/681,396 Takada , et al. March 25, 2
2014-03-25
Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same
8,679,502 - 12/681,396 Takada , et al. March 25, 2
2014-03-25
Monoclonal antibody capable of binding to specific discontinuous epitope occurring in AD1 region of human cytomegalovirus GB glycoprotein, and antigen-binding fragment thereof
8,492,529 - 13/262,061 Takada , et al. July 23, 2
2013-07-23
Monoclonal antibody capable of binding to specific discontinuous epitope occurring in AD1 region of human cytomegalovirus GB glycoprotein, and antigen-binding fragment thereof
8,492,529 - 13/262,061 Takada , et al. July 23, 2
2013-07-23
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed